STAYBLE THERAPEUTICS AB has a total of 28 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are TO PHARMACEUTICALS LLC, HAVAH THERAPEUTICS PTY LTD and SHURDOV MIKHAIL ARKAD EVICH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Israel | 3 | |
#5 | Australia | 2 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Russian Federation | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 | |
#11 | Hungary | 1 | |
#12 | Serbia | 1 | |
#13 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Olmarker Kjell | 20 |
#2 | Kjell Olmarker | 5 |
#3 | Olmarker Chell | 2 |
Publication | Filing date | Title |
---|---|---|
RU2731405C2 | Composition for use in treating intervertebral disk-related pain | |
HUE046209T2 | A composition for use in the treatment of intervertebral disc-related pain | |
SE1550338A1 | A composition for use in the treatment of intervertebral misalignment |